Twins can be used to investigate the biological basis for observed associations between birth weight and later disease risk, as they experience in utero growth restriction compared with singletons, which can differ in magnitude within twin pairs despite partial or total genetic identity. In the present study, sixty monozygotic and seventy-one dizygotic same-sex twin pairs aged 19-50 years and eighty-nine singleton controls matched for age, gestational age, sex, maternal age and parity were recruited from an obstetric database. Associations between fasting lipid levels and birth weight were assessed by linear regression with adjustment for possible confounding factors. Twins were significantly lighter at birth but were not significantly different in adult height, weight or lipid levels from the singleton controls. There was a significant inverse association between birth weight and both total and LDL-cholesterol levels among singleton controls (20·53 mmol/l per kg (95 % CI 20·97, 20·09), P¼0·02 and 20·39 mmol/l per kg (95 % CI 20·76, 20·02), P¼ 0·04, respectively), but there was no significant association between birth weight and lipid levels in either unpaired or within-pair analysis of twins. The results suggest that the in utero growth restriction and early catch-up growth experienced by twins does not increase the risk of an atherogenic lipid profile in adult life.
Birth weight: Lipid levels: Twins
An association between birth weight and adult susceptibility to CVD, diabetes and hypertension has been reported by a number of groups in widely different cultural settings (Barker et al. 1993; Curhan et al. 1996; Stein et al. 1996; Rich-Edwards et al. 1997 , 1999 Forsen et al. 1999; Huxley et al. 2000; Burke et al. 2004 ). The 'fetal origins' hypothesis proposes that this association is causal as a result of 'predictive adaptive responses' made by the fetus to undernutrition in utero, which persist into adulthood and increase susceptibility to the metabolic effects of overnutrition in later life (Barker, 1995 (Barker, , 1998 (Barker, , 1999 Gluckman & Hanson, 2004) . Although in man the evidence for a close relationship between birth weight and maternal diet is limited, intervention studies in animals provide support for the possibility that maternal nutrient intake may influence both size at birth and later disease risk (McMillen & Robinson, 2005) .
Although much of the literature on the fetal origins hypothesis has focused on hypertension and insulin resistance, increased plasma lipid levels are also a major independent risk factor for CVD (Poulter, 2003) . A systematic review of thirty-two studies in singletons found a weak inverse association between birth weight and total cholesterol (Owen et al. 2003) , but a more recent review of seventynine studies concluded that impaired fetal growth does not have effects on blood cholesterol levels that would have a material impact on vascular disease risk (Huxley et al. 2004) . Another systematic review of thirty-nine studies, which included other lipid measures, also concluded that there was no consistent relationship between size at birth and blood lipid concentrations in later life, with the possible exception of a negative association between birth weight and triacylglycerol concentration (Laurèn et al. 2003) . Thus, there remains considerable uncertainty as to the strength of the relationship with birth weight and, if the relationship does exist, whether fetal undernutrition is the underlying mechanism. One alternative interpretation is that the same genes that predispose to adult disease also result in low birth weight (Hattersley & Tooke, 1999; Eriksson et al. 2002) as there is evidence that genetic factors contribute to the variation in birth weight (Magnus, 1984; Magnus et al. 1997 ) and lipid levels (Boekholdt et al. 2004) . Twin studies provide an opportunity to separate the influence of the early environment and the influence of genetic factors, since twins experience in utero growth restriction and in addition experience postnatal catch-up growth, which has been identified as an additional risk factor for later CVD in singletons . Furthermore, the importance of genetic factors in explaining an association between birth weight and disease risk can be assessed by comparing the magnitude of the effect in dizygotic v. monozygotic twin pairs. A recent study of adolescent twins using this approach found significant correlations in dizygotic but not monozygotic pairs, which suggested that genetic factors contribute to the relationship between birth weight and later plasma lipid concentrations (Ijzerman et al. 2001 ). However, another study found that in monozygotic twin pairs the lower-birth-weight twins tended to have higher triacylglycerol and lower HDL-cholesterol levels than the higher-weight twins, suggesting that non-genetic factors play a role in this relationship (Bo et al. 2001) .
We have previously reported the results of a study of adult twins and singleton controls designed to investigate whether genetic factors contribute to association between size at birth and blood pressure, insulin resistance and fibrinogen levels in adult life Tuya et al. 2003 Tuya et al. , 2005 . In the present paper we explore the relationship between birth weight and fasting lipid concentrations using the same study design. We also report the total genetic contribution to variation in the lipid levels based on the classical twin study design.
Methods

Subjects
The Aberdeen Maternity and Neonatal Databank is a computerised register of all births that have occurred at Aberdeen Maternity Hospital in Aberdeen, Scotland, since 1949. It contains detailed obstetric information including gestation and birth weight recorded at delivery. Between 1949 and 1980 there were 792 same-sex-twin live births at Aberdeen Maternity Hospital. Of these, 465 twin pairs (59 %) in which one or both twins were living in the Grampian region were traced via the local Community Health Index (a database of all individuals registered with the National Health Service) in 1999. To identify singleton controls, each twin delivery was matched with up to four live singleton deliveries of the same sex, gestational age (^1 week), maternal age (^5 years) and parity (0, 1 or $ 2), and year of birth (^1 year). Of these, 442 individuals living in Grampian were traced through the Community Health Index. In fifteen twin pairs, one or both twins were excluded by the family doctor for medical reasons, as was one singleton. All others were sent a letter of information about the study and 131 twin pairs (32 %) and ninety-three singletons (21 %) agreed to participate and attended for measurements. Acute and/or chronic illness was excluded using a standardised questionnaire. Four singletons were later excluded from analysis as a result of errors discovered in the matching of singleton and twin deliveries. The effect of oral contraceptives on lipid levels was assessed by linear regression with adjustment for oral contraceptive use. None of the subjects used any other medication that may affect serum lipid profile. Thus, 131 twin pairs and eighty-nine singleton controls were eligible for analysis.
Measurements and questionnaire
Measurements were made of height, weight and waist circumference in each subject. BMI was calculated (kg/m 2 ). Body fat was measured by bioelectrical impedance analysis using the Bodystat w 1500 (Bodystat Ltd, Isle of Man). Medical details, smoking and occupation were obtained by a questionnaire based on that used in the Scottish MONICA study (Smith et al. 1989 ). The physical activity questions were a modified version of those used for the Framingham Physical Activity Index (Kannel & Sorlie, 1979) . Diet was assessed using version 6.31 of the Scottish Collaborative Group semi-quantitative food-frequency questionnaire .
Clinical and laboratory investigations
An overnight fasting venous blood sample was taken for measurements of cholesterol, triacylglycerols and apolipoproteins. Total cholesterol, HDL-cholesterol and triacylglycerols were measured on the Bayer ADVIA 1650 w (Bayer Healthcare, Newbury, UK) and LDL-cholesterol was calculated using the Friedewald equation (Friedewald et al. 1972) . Apo A1 and apo B were measured by in vitro diagnostic reagents N Antisera using the Behring Rate Nephelometer (Dade Behring Ltd, Milton Keynes, UK). The interassay CV was , 2 % for total cholesterol and triacylglycerols. For all other assays it was , 5 %. The laboratory references for all analytes were in the relevant United Kingdom National Quality Assurance Scheme.
Birth weight, gestational age, maternal age and parity for both twins and controls were obtained from obstetric records in the Aberdeen Maternity Neonatal Databank. Self-reported birth order was used to link the relevant obstetric information from the Aberdeen Maternity Neonatal Databank to individual twins from each pair. Zygosity was determined by DNA fingerprinting using a venous blood sample. Ten short tandem repeats were analysed using the AmpFLSTR Profiler on the ABI 310 genetic analyzer (Applied Biosystems, Foster City, CA, USA).
The study protocol was approved by the Grampian Research Ethics Committee, and all subjects gave informed written consent to participate.
Statistical analysis
The contribution of genetic and shared and non-shared environmental effects for the total variation in lipid risk factors was assessed using an ACE twin model using the Mx program (Neale et al. 2004) for twin data (Purcell, 2000) . This partitions the total variance in a trait into Additive genetic variance and Common (shared) and unique Environmental effects. The variance-covariance matrix for each of the parameters was calculated for the monozygotic and dizygotic twins following adjustment by multiple regression. In the basic model only sex and age were adjusted for, while in the fully adjusted model the data were adjusted for sex, age, percentage body fat, dietary polyunsaturated:saturated fatty acid ratio, dietary percentage energy as fat, physical activity level, and the use of oral contraceptives.
Differences in birth weight, anthropometric variables and lipid measurements between twins and singleton controls were assessed by Mann -Whitney tests. The relationships between birth weight and adult lipid levels were assessed by linear regression with adjustment for current age, sex, gestational age, percentage body fat, physical activity, oral contraceptive use, percentage energy from fat and polyunsaturated:saturated fatty acid ratio. Regression coefficients for the relationships between lipid levels and birth weight in the unpaired analysis in twins were estimated using generalised estimating equations with an exchangeable correlation structure to model the correlated nature of the sample.
In addition, linear regression analysis was used to assess the association between within-pair differences in birth weight and differences in lipid levels before and after adjustment for differences in confounding variables. In within-pair analysis the differences between first-and second-born twins were used rather than the differences between heavier and lighter twins at birth, as the range of birth-weight differences is wider with both positive and negative values in the former than the latter, which improves the estimation of the regression coefficient (Bring & Wernroth, 1999) . Difference in oral contraceptive use was assessed by coding twins on oral contraceptive, not on oral contraceptive but co-twins on oral contraceptive, and not on oral contraceptive, as 2, 1, and 0 respectively, and subtracting the code for the second-born twin from that for the first-born twin. These analyses were carried out using SPSS version 11 (SPSS Inc., Chicago, IL, USA) and STATA version 7.0 (StataCorp LP, College Station, TX, USA).
Results
There were no significant differences in current age, birth weight, gestational age or maternal parity between participants and nonparticipants, although the percentage of female twins who participated was higher than the percentage of male twins (Table 1) .
The birth weights, adult characteristics and lipid profile of the participating twins and singleton controls are shown in Tables 2  and 3 . Male participants were slightly older than female participants in both twins (P, 0·001) and singleton controls (P, 0·05), which may reflect difficulties involved in tracing older women as a result of changes of names on marriage. As expected the singleton controls (both males and females) had a significantly higher birth weight than the twins (P, 0·001 for both), even though there was no difference in gestational age. However, there were no differences in plasma lipid concentrations, adult height and weight, or BMI between twins and singletons in either males or females.
Among the twins, birth weight and gestational age were not significantly different between monozygotic and dizygotic twins (data not shown), but current age was significantly higher in dizygotic twins than in monozygotic twins among both males and females (P¼0·05 and P¼0·04, respectively). Adult weight, BMI, percentage body fat and triacylglycerol levels were also significantly higher in dizygotic twins than in monozygotic twins among the males (P¼0·02, P¼0·01, P¼0·005 and P¼0·006, respectively). Table 4 shows the results of the ACE analysis, which indicate that 40 -50 % of the variance in HDL-cholesterol and apo A1 was genetically determined. In the case of apo B about 60 % of the variation was genetically determined, but this effect appeared to be operating largely via a genetic influence on the percentage body fat as adjustment for this factor in particular was largely responsible for the removal of the genetic effect in the fully adjusted model. The model also calculated a genetic influence on LDL-cholesterol of the same order of magnitude but this was not significant because of the high variance in this parameter in the dizygotic twins in particular. As with apo B, even this non-significant effect was removed after full adjustment, again largely due to the effect of body fat.
Although there was a wide range of within-pair differences in birth weight, adult height, BMI and lipid concentrations in all variables, for example, up to 1·8 kg in birth weight and up to 3·8 mmol/l in total cholesterol concentrations, the range of within-pair differences was similar in monozygotic and dizygotic twin pairs (data not shown). Table 5 shows the regression coefficients for the association between birth weight and lipid levels in singletons and twins. There was a significant negative relationship between within-pair differences in birth weight and differences in both total and HDLcholesterol in monozygotic twins, in the unadjusted analyses (2 0·29 mmol/l per kg (95 % CI 2 0·49, 2 0·09), P¼ 0·004 and 2 0·11 mmol/l per kg (95 % CI 0·22, 0·00), P¼ 0·04, respectively), but this was not seen in the adjusted models. In the analysis of all twins, both unadjusted and adjusted regression coefficients were small and were not statistically significant. However, in singleton controls, there were significant inverse associations between birth weight and both total and LDL-cholesterol concentrations in the adjusted models.
Discussion
Despite the smaller numbers of singleton controls in the present study, we found a significant inverse association between birth weight and lipid levels in the singleton controls. This was in line with the inverse associations between birth weight and diastolic blood pressure, glycated Hb (HbA 1 C) and clottable fibrinogen observed in these subjects Tuya et al. 2003 Tuya et al. , 2005 . The possibility that genetic factors might contribute to this association was supported by the observation that in the twins the ACE analysis confirmed the importance of genetic factors in determining lipid levels. However, in the unpaired analysis in twins we found no association between birth weight and lipid levels. In addition there was no difference in lipid levels between the twins and singleton controls despite the lower birth weight and postnatal catch-up growth in the twins. Taken together, these results suggest that the type of intra-uterine growth restriction and postnatal catch-up growth seen in twins does not have an adverse effect on lipid levels in later life. Phillips et al. (2001) suggested that small size at birth in twins may not have the same origin as small size in singletons, which could be due to the fact that growth restriction in twins only occurs from about 32 weeks (Loos et al. 2005 ). Gluckman & Hanson (2004) also raised the possibility that maternal constraint on fetal growth as a result of increased fetal demand for nutrients, as seen in multiple pregnancies, could have different mechanisms from that due to decreased maternal supply. Another factor that may influence birth weight in monozygotic twins is twin-twin transfusion syndrome, which can occur in two-thirds of monozygotic twin pairs that are monochorionic, and may result in birth-weight discordance and blood lipid level differences through mechanisms not experienced by singletons (Lopiore et al. 2003) . It was not possible to explore this aspect in the present study, as chorionicity information was only recorded in twentynine of the sixty monozygotic pairs. For postnatal growth it is also possible that the pattern of catch-up growth seen in twins, which mostly occurs in the first 2 years of life (Keet et al. 1986) , may have different effects to accelerated growth or overnutrition in later childhood. Another way in which twins could differ from singletons is in infant feeding, as twins may be breast-fed less commonly or for shorter periods than singletons; breast-feeding in the Caerphilly study was found to be associated with CHD mortality and incidence (Martin et al. 2005) . However, the subjects of the present study were born at a time when infant formulae were more similar in composition to breast milk; in addition, twins within a pair are likely to have been fed by the same method so the within-pair analyses are unlikely to be influenced by this issue. As there was no association between birth weight and lipid levels in the unpaired twins it was not surprising that there was no evidence for an attenuation of the effect in the within-pair analysis in monozygotic v. dizygotic pairs. This is in contrast to a recent study of adolescent twins (sixty-one monozygotic and fifty-three dizygotic pairs), which found that low birth weight was associated with high total and LDL-cholesterol in dizygotic twin pairs, but with low total and LDL-cholesterol in monozygotic twin pairs, suggesting a genetic effect on the association (Ijzerman et al. 2001) , although the unpaired analysis in twins was not presented. It is not clear why the results of the two studies differ; the major difference is that in the present study the subjects were older, but the influence of birth weight on cardiovascular risk factors might be expected to increase rather than decrease with age. In the study of Ijzerman et al. (2001) , birth weight was ascertained from the mothers by questionnaire and zygosity was determined by similarity questions, while in our subjects birth weight was obtained from medical records and zygosity was determined through sequential analysis based on DNA fingerprints, so it is unlikely that errors in zygosity or birth weight could account for the lack of effect in the present study.
In summary we found evidence for an inverse association between birth weight and total and LDL-cholesterol in singletons and for a genetic influence on lipid levels in the twins. No association between birth weight and lipid levels was seen in unpaired twins, and there was no significant difference in adult lipid levels between the twins and the singleton controls. Differences in growth patterns in prenatal and early postnatal life between twins and singletons may help to identify the nature and timing of early life influences on adult disease risk.
